Magnetic Resonance Imaging of the Lung: Oncological Applications
NCT07486219 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-03-20
Summary
Lung neoplasms are characterized by a complex interaction between tumor cells and a variety of resident and infiltrating host elements, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Nowadays, in the setting of lung cancer, and in particular non-small cell lung cancer (NSCLC), the evaluation of microenvironment characteristics can only be performed by a pathologist and only on histological material. By combining different MRI parameters, it may be possible to create a specific imaging "signature" for the three different immune phenotypes and thus be able to make a distinction based on MRI examination.
Conditions
- Lung Cancer (NSCLC)
Sponsors & Collaborators
-
Fondazione IRCCS Policlinico San Matteo di Pavia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-15
- Primary Completion
- 2026-04-30
- Completion
- 2026-04-30
Countries
- Italy
Study Locations
More Related Trials
-
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
NCT05699213 ·Status: RECRUITING
-
Radiomics: a Study of Outcome in Lung Cancer
NCT01302626 ·Status: COMPLETED
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
NCT01799135 ·Status: TERMINATED ·Phase: NA
-
LC-NMR Study Biomarkers to Detect Lung Cancer
NCT02024113 ·Status: COMPLETED
-
Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis
NCT07396467 ·Status: ACTIVE_NOT_RECRUITING
-
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
NCT00264602 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung Cancer
NCT06742021 ·Status: RECRUITING ·Phase: NA
-
Intraoperative Imaging of Pulmonary Nodules by OTL38
NCT02602119 ·Status: COMPLETED ·Phase: PHASE1
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Radiomics Multifactorial Biomarker for Pulmonary Nodules
NCT03872362 ·Status: COMPLETED
-
Benefit of Spectral Information in Patients Suspected for Lung Cancer
NCT06440616 ·Status: RECRUITING ·Phase: NA
-
Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung Cancer
NCT03954847 ·Status: UNKNOWN
-
18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC
NCT07449858 ·Status: ACTIVE_NOT_RECRUITING
-
Early Detection of Lung Cancer In Patients With Chronic Chest Diseases
NCT06074978 ·Status: NOT_YET_RECRUITING
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer
NCT02497586 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Regional Lung Ventilation
NCT03077113 ·Status: COMPLETED ·Phase: NA
-
Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC)
NCT01065415 ·Status: COMPLETED
-
Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer
NCT01551251 ·Status: COMPLETED
-
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
NCT01936571 ·Status: COMPLETED
-
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer
NCT06194630 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 ·Status: RECRUITING